Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001192482-21-000032

Options or other derivatives

  • Director acquired 3,877 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gutry Phil · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-12-31 Grant or award : show line 1 in the form Stock Option (Right to Buy) +3,877 $2.64 2030-12-31 3,877 3,877 D
Loading xslF345X03/edgar.xml…